Acupuncture Treatment for Schizophrenia-related Central Obesity
Study on the Optimal Scheme of Acupuncture Treatment for Schizophrenia-related Central Obesity
1 other identifier
interventional
150
1 country
2
Brief Summary
This clinical trial aims to test the effect of acupuncture in patients with schizophrenia-related central obesity. The main question it aims to answer is: • The effect, safety, and maintenance of acupuncture on schizophrenia-related central obesity. Participants will receive acupuncture treatment on purpose acupoints, acupuncture on acupoint peripheries, or fake acupuncture treatment on purpose acupoints for 20 weeks. And they need three follow-up visits during the treatment period and two follow-up visits after treatment. Researchers will compare the waist circumstance of these three groups to see if the purpose acupoints are valid for schizophrenia-related central obesity.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable schizophrenia
Started Oct 2022
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2022
CompletedFirst Submitted
Initial submission to the registry
February 26, 2023
CompletedFirst Posted
Study publicly available on registry
April 27, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2024
CompletedApril 27, 2023
January 1, 2023
1.9 years
February 26, 2023
April 16, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Change from Baseline Waist Circumference at 8 weeks, 16 weeks, 20 weeks, 32 weeks, respectively
Waist Circumference in centimiter
Baseline, 8 weeks, 16 weeks, 20 weeks, 32 weeks
Secondary Outcomes (13)
Change from Baseline Body Weight Index at 8 weeks, 16 weeks, 20 weeks, 32 weeks, respectively
Baseline, 8 weeks, 16 weeks, 20 weeks, 32 weeks
Change from Baseline Hip Circumference at 8 weeks, 16 weeks, 20 weeks, 32 weeks, respectively
Baseline, 8 weeks, 16 weeks, 20 weeks, 32 weeks
Change from Baseline both Blood Pressure at 8 weeks, 16 weeks, 20 weeks, 32 weeks, respectively
Baseline, 8 weeks, 16 weeks, 20 weeks, 32 weeks
Change from Baseline Blood Triglyceride at 16 weeks, 32 weeks, respectively
Baseline, 16 weeks, 32 weeks
Change from Baseline Blood Total Cholesterol at 16 weeks, 32 weeks, respectively
Baseline, 16 weeks, 32 weeks
- +8 more secondary outcomes
Study Arms (3)
Acupuncture Group
EXPERIMENTALThey receive actual acupuncture on purpose acupoints.
Sham Group
SHAM COMPARATORThey receive actual acupuncture on points but not an acupoint around the purpose acupoints.
non-Acupuncture Group
SHAM COMPARATORThey receive fake acupuncture (no needle) on purpose acupoints.
Interventions
All the groups receive respective treatment 3 times a week for the first eight weeks, twice a week for another 8 weeks, and once a week for the last 4 weeks.
Eligibility Criteria
You may qualify if:
- Diagnosis with schizophrenia (Diagnostic and Statistical Manual of Mental Disorders: Fifth Edition);
- Continuous use of antipsychotics for more than one year (may be combined with mood stabilizers, antianxiety medications, antidepressants, and benzodiazepines);
- Abdominal obesity (central obesity): waist circumference ≥90cm for men or ≥85cm for women (Chinese Standard);
- All participants and their guardians signed informed consent.
You may not qualify if:
- Had various traditional Chinese medicine or chemical drugs, or acupuncture treatments for central obesity within two weeks before enrollment;
- Pregnant or lactating woman;
- Organic mental disorders and mental disorders induced by psychoactive and non-addictive substances;
- With other diseases affecting their mental state (e.g., chronic obstructive pulmonary disease, coronary heart disease, angina pectoris, stroke, painful joint diseases, severe psychiatric diseases, tumors, and other physical diseases)
- Severe liver and kidney insufficiency or other serious diseases of the system;
- With a family history of metabolic diseases such as hypertension, diabetes, and hyperlipidemia;
- Acupuncture dizziness, needle phobia, and other intolerant acupuncture treatment;
- Patients who are not treated according to the regulations, cannot determine the efficacy or have incomplete data affecting the efficacy and safety evaluation.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Shanghai Mental Health Center
Shanghai, Shanghai Municipality, 200030, China
Shanghai Huangpu Mental Health Center
Shanghai, Shanghai Municipality, China
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 26, 2023
First Posted
April 27, 2023
Study Start
October 1, 2022
Primary Completion
September 1, 2024
Study Completion
September 30, 2024
Last Updated
April 27, 2023
Record last verified: 2023-01
Data Sharing
- IPD Sharing
- Will share